
Using existing clinical trial data to proactively model patient safety and efficacy outcomes could aid in accelerating development for areas in need of new therapies.
Chief Operations Officer, Phesi
Using existing clinical trial data to proactively model patient safety and efficacy outcomes could aid in accelerating development for areas in need of new therapies.
Phesi and Tufts CSDD share results from research on operating practices that can be improved.
Digital twins, defined as a typical demographic patient profile in a specific population, have the potential to help clinical trial design.
Analysis of 330,000 clinical trials calls for improved protocol design process.
Case study shows that site activation is a key driver in determining patient enrollment cycle time, which can be minimized by identifying the "sweet spot" of sites to deploy for a clinical trial.
Case study demonstrates that site activation is a key driver in determining patient enrollment cycle time.
Published: April 13th 2021 | Updated:
Published: April 22nd 2022 | Updated:
Published: January 17th 2018 | Updated:
Published: January 17th 2018 | Updated: